| 摘要 |
The purpose of the present invention is to provide a diagnostic agent and a diagnostic method for appropriately diagnosing fibromyalgia of a specific type, and a therapeutic agent for the aforesaid type. The invention relates to: a diagnostic agent for fibromyalgia relating to an anti-voltage-gated potassium channel complex antibody (anti-VGKC complex antibody), said diagnostic agent comprising a reagent for detecting the anti-VGKC complex antibody; a diagnostic method using the diagnostic agent; and a therapeutic agent for fibromyalgia relating to the anti-VGKC complex antibody. The invention relates to: a diagnostic agent for fibromyalgia relating to an antibody against a voltage-gated potassium channel complex, said diagnostic agent comprising a reagent for detecting the antibody against the voltage-gated potassium channel complex; and a therapeutic agent for fibromyalgia relating to an antibody against voltage-gated potassium channel, said therapeutic agent comprising an effective amount of an anticonvulsant drug (gabapentine or clonazepam) as the active ingredient. |
